David Einhorn Intercept Pharmaceuticals, Inc. Transaction History

Greenlight Capital Inc

  • $1.97 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$19.33 - $37.75 $1.58 Million - $3.09 Million
-81,856 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$24.48 - $42.47 $444,165 - $770,575
-18,144 Reduced 18.14%
81,856 $2.02 Million
Q3 2020

Nov 16, 2020
BUY
$39.09 - $53.44 $3.91 Million - $5.34 Million
100,000 New
100,000 $4.15 Million

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track David Einhorn's Portfolio

Track David Einhorn Portfolio

Follow David Einhorn (Greenlight Capital Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenlight Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenlight Capital Inc and David Einhorn with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email